只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-31 2026-07-31 | UMBF UMB FINANCIAL CORP | Beaird Robert Brian Officer · Chief Human Resource Officer | 卖出（S） | 1,600 | US$144.40 | US$231,040.00 | 8,943.3509 | SEC |
| 2026-07-23 2026-07-27 | IRD Opus Genetics, Inc. | Gagnon Robert E. Officer · Chief Financial Officer | 卖出（S） | 7,783 | US$2.95 | US$22,941.95 | 584,375 | SEC |
| 2026-07-23 2026-07-27 | IRD Opus Genetics, Inc. | Magrath George Director,Officer · Chief Executive Officer | 卖出（S） | 9,475 | US$2.95 | US$27,925.67 | 1,731,869 | SEC |
| 2026-07-23 2026-07-27 | IRD Opus Genetics, Inc. | SCHACHLE JOSEPH K Officer · Chief Operating Officer | 卖出（S） | 4,644 | US$2.94 | US$13,653.36 | 291,440 | SEC |
| 2026-07-23 2026-07-27 | IRD Opus Genetics, Inc. | YERXA BENJAMIN R Director,Officer · President | 卖出（S） | 7,429 | US$2.97 | US$22,064.13 | 704,106 | SEC |
| 2026-06-25 2026-06-26 | BIRD Smartbird, Inc. | Carlsten Nadia Catherine Director,Officer · Chief Executive Officer | 卖出（S） | 117,459 | US$4.21 | US$494,502.39 | 1,414,920 | SEC |
| 2026-06-15 2026-06-16 | TCBX Third Coast Bancshares, Inc. | Glander Troy Andrew Director | 卖出（S） | 2,500 | US$40.29 | US$100,725.00 | 27,651 | SEC |
| 2026-06-10 2026-06-12 | LSF Laird Superfood, Inc. | GRAVES GREGORY B Director | 买入（P） | 15,000 | US$3.45 | US$51,750.00 | 75,089 | SEC |
| 2026-06-05 2026-06-09 | LSF Laird Superfood, Inc. | LaMontagne Grant J Director | 买入（P） | 6,910 | US$3.30 | US$22,803.00 | 175,244 | SEC |
| 2026-06-04 2026-06-09 | LSF Laird Superfood, Inc. | LaMontagne Grant J Director | 买入（P） | 8,826 | US$3.23 | US$28,507.98 | 168,334 | SEC |
| 2026-06-03 2026-06-09 | LSF Laird Superfood, Inc. | LaMontagne Grant J Director | 买入（P） | 17,054 | US$3.30 | US$56,278.20 | 159,508 | SEC |
| 2026-06-02 2026-06-09 | LSF Laird Superfood, Inc. | LaMontagne Grant J Director | 买入（P） | 27,160 | US$3.30 | US$89,628.00 | 142,454 | SEC |
| 2026-06-02 2026-06-03 | BIRD Allbirds, Inc. | Vernachio Joseph Director,Officer · Chief Executive Officer | 卖出（S） | 3,359 | US$4.47 | US$15,014.73 | 82,210 | SEC |
| 2026-06-02 2026-06-03 | BIRD Allbirds, Inc. | Mitchell Ann Officer · Chief Financial Officer | 卖出（S） | 1,587 | US$4.52 | US$7,173.24 | 76,188 | SEC |
| 2026-05-29 2026-06-01 | LSF Laird Superfood, Inc. | LaMontagne Grant J Director | 买入（P） | 6,610 | US$3.30 | US$21,813.00 | 115,294 | SEC |
| 2026-05-28 2026-06-01 | LSF Laird Superfood, Inc. | LaMontagne Grant J Director | 买入（P） | 624 | US$3.30 | US$2,059.20 | 108,684 | SEC |
| 2026-05-26 2026-05-28 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures V, L.P. TenPercentOwner | 卖出（S） | 18,572 | US$40.05 | US$743,808.60 | 6,280,525 | SEC |
| 2026-05-26 2026-05-28 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures VI, L.P. TenPercentOwner | 卖出（S） | 18,572 | US$40.05 | US$743,808.60 | 6,280,525 | SEC |
| 2026-05-26 2026-05-28 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures GP VI, L.P. TenPercentOwner | 卖出（S） | 18,572 | US$40.05 | US$743,808.60 | 6,280,525 | SEC |
| 2026-05-26 2026-05-28 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures GP V, LP TenPercentOwner | 卖出（S） | 18,572 | US$40.05 | US$743,808.60 | 6,280,525 | SEC |
| 2026-05-22 2026-06-01 | LSF Laird Superfood, Inc. | LaMontagne Grant J Director | 买入（P） | 615 | US$3.30 | US$2,029.50 | 108,060 | SEC |
| 2026-05-21 2026-06-01 | LSF Laird Superfood, Inc. | LaMontagne Grant J Director | 买入（P） | 87 | US$3.30 | US$287.10 | 107,445 | SEC |
| 2026-05-20 2026-06-01 | LSF Laird Superfood, Inc. | LaMontagne Grant J Director | 买入（P） | 22,850 | US$3.28 | US$74,948.00 | 107,358 | SEC |
| 2026-05-19 2026-05-20 | BLBD Blue Bird Corp | Thau Daniel Mark Director | 买入（P） | 300 | US$65.09 | US$19,527.00 | 8,696 | SEC |
| 2026-05-18 2026-05-29 | TREIX Thirdline Real Estate Income Fund | Eiben Lawrence Scott Director,Officer · Principal Financial Officer | 卖出（S） | 60,361.05 | US$9.18 | US$554,114.44 | 233,901.84 | SEC |
| 2026-05-18 2026-05-20 | IRD Opus Genetics, Inc. | Foundation Fighting Blindness Retinal Degeneration Fund Director,Other | 卖出（S） | 1,700,000 | US$4.35 | US$739.5万 | 3,792,171 | SEC |
| 2026-05-18 2026-05-20 | IRD Opus Genetics, Inc. | Foundation Fighting Blindness, Inc. Director,Other | 卖出（S） | 1,700,000 | US$4.35 | US$739.5万 | 3,792,171 | SEC |
| 2026-05-11 2026-05-13 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures V, L.P. TenPercentOwner | 卖出（S） | 133,618 | US$40.24 | US$537.68万 | 6,299,097 | SEC |
| 2026-05-11 2026-05-13 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures VI, L.P. TenPercentOwner | 卖出（S） | 133,618 | US$40.24 | US$537.68万 | 6,299,097 | SEC |
| 2026-05-11 2026-05-13 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures GP VI, L.P. TenPercentOwner | 卖出（S） | 133,618 | US$40.24 | US$537.68万 | 6,299,097 | SEC |
| 2026-05-11 2026-05-13 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures GP V, LP TenPercentOwner | 卖出（S） | 133,618 | US$40.24 | US$537.68万 | 6,299,097 | SEC |
| 2026-05-08 2026-05-11 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures VI, L.P. TenPercentOwner | 卖出（S） | 5,018 | US$40.31 | US$202,275.58 | 6,432,715 | SEC |
| 2026-05-08 2026-05-11 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures V, L.P. TenPercentOwner | 卖出（S） | 5,018 | US$40.31 | US$202,275.58 | 6,432,715 | SEC |
| 2026-05-08 2026-05-11 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures GP VI, L.P. TenPercentOwner | 卖出（S） | 5,018 | US$40.31 | US$202,275.58 | 6,432,715 | SEC |
| 2026-05-08 2026-05-11 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures GP V, LP TenPercentOwner | 卖出（S） | 5,018 | US$40.31 | US$202,275.58 | 6,432,715 | SEC |
| 2026-05-07 2026-05-11 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures VI, L.P. TenPercentOwner | 卖出（S） | 271,495 | US$40.12 | US$1089.24万 | 6,437,733 | SEC |
| 2026-05-07 2026-05-11 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures V, L.P. TenPercentOwner | 卖出（S） | 271,495 | US$40.12 | US$1089.24万 | 6,437,733 | SEC |
| 2026-05-07 2026-05-11 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures GP VI, L.P. TenPercentOwner | 卖出（S） | 271,495 | US$40.12 | US$1089.24万 | 6,437,733 | SEC |
| 2026-05-07 2026-05-11 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures GP V, LP TenPercentOwner | 卖出（S） | 271,495 | US$40.12 | US$1089.24万 | 6,437,733 | SEC |
| 2026-04-30 2026-05-04 | SRAD Sportradar Group AG | Bigley Deirdre Mary Director | 买入（P） | 3,940 | US$12.57 | US$49,525.80 | 13,897 | SEC |
| 2026-04-28 2026-04-29 | FITB FIFTH THIRD BANCORP | Sefzik Peter L Officer · EVP | 卖出（S） | 18,767 | US$50.46 | US$946,982.82 | 189,682 | SEC |
| 2026-04-28 2026-04-29 | FITB FIFTH THIRD BANCORP | Sefzik Peter L Officer · EVP | 卖出（S） | 100 | US$50.47 | US$5,047.00 | 189,582 | SEC |
| 2026-04-28 2026-04-29 | FITB FIFTH THIRD BANCORP | Sefzik Peter L Officer · EVP | 卖出（S） | 200 | US$50.47 | US$10,094.00 | 189,382 | SEC |
| 2026-04-28 2026-04-29 | FITB FIFTH THIRD BANCORP | Sefzik Peter L Officer · EVP | 卖出（S） | 100 | US$50.45 | US$5,045.00 | 208,884 | SEC |
| 2026-04-28 2026-04-29 | FITB FIFTH THIRD BANCORP | Sefzik Peter L Officer · EVP | 卖出（S） | 398 | US$50.44 | US$20,075.12 | 208,984 | SEC |
| 2026-04-28 2026-04-29 | FITB FIFTH THIRD BANCORP | Sefzik Peter L Officer · EVP | 卖出（S） | 435 | US$50.45 | US$21,945.75 | 208,449 | SEC |
| 2026-04-23 2026-04-27 | IRD Opus Genetics, Inc. | Gagnon Robert E. Officer · Chief Financial Officer | 卖出（S） | 7,842 | US$5.18 | US$40,621.56 | 592,158 | SEC |
| 2026-04-23 2026-04-27 | IRD Opus Genetics, Inc. | Jayagopal Ashwath Officer · Chief Scientific & Dev. Ofc. | 卖出（S） | 7,542 | US$5.19 | US$39,142.98 | 509,233 | SEC |
| 2026-04-23 2026-04-27 | IRD Opus Genetics, Inc. | Magrath George Director,Officer · Chief Executive Officer | 卖出（S） | 9,511 | US$5.22 | US$49,647.42 | 1,741,344 | SEC |
| 2026-04-23 2026-04-27 | IRD Opus Genetics, Inc. | Zaremba Rabourn Amy Officer · Head of Fin. Quality Assurance | 卖出（S） | 1,641 | US$5.20 | US$8,533.20 | 188,671 | SEC |
| 2026-04-23 2026-04-27 | IRD Opus Genetics, Inc. | SCHACHLE JOSEPH K Officer · Chief Operating Officer | 卖出（S） | 4,697 | US$5.22 | US$24,518.34 | 296,084 | SEC |
| 2026-04-23 2026-04-27 | IRD Opus Genetics, Inc. | YERXA BENJAMIN R Director,Officer · President | 卖出（S） | 7,470 | US$5.24 | US$39,142.80 | 711,535 | SEC |
| 2026-04-20 2026-04-21 | FITB FIFTH THIRD BANCORP | Khanna Kevin J Officer · EVP | 卖出（S） | 2,000 | US$50.78 | US$101,560.00 | 76,299 | SEC |
| 2026-04-20 2026-04-21 | FITB FIFTH THIRD BANCORP | Khanna Kevin J Officer · EVP | 卖出（S） | 4,000 | US$50.77 | US$203,080.00 | 78,299 | SEC |
| 2026-04-17 2026-04-21 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures VI, L.P. TenPercentOwner | 卖出（S） | 426,005 | US$40.32 | US$1717.65万 | 6,709,228 | SEC |
| 2026-04-17 2026-04-21 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures V, L.P. TenPercentOwner | 卖出（S） | 426,005 | US$40.32 | US$1717.65万 | 6,709,228 | SEC |
| 2026-04-17 2026-04-21 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures GP VI, L.P. TenPercentOwner | 卖出（S） | 426,005 | US$40.32 | US$1717.65万 | 6,709,228 | SEC |
| 2026-04-17 2026-04-21 | RAPP Rapport Therapeutics, Inc. | Third Rock Ventures GP V, LP TenPercentOwner | 卖出（S） | 426,005 | US$40.32 | US$1717.65万 | 6,709,228 | SEC |
| 2026-04-06 2026-04-06 | IRDM Iridium Communications Inc. | Kapalka Timothy Officer · CAO Iridium Satellite LLC | 卖出（S） | 2,043 | US$33.00 | US$67,419.00 | 45,721 | SEC |
| 2026-04-02 2026-04-06 | IRDM Iridium Communications Inc. | Kapalka Timothy Officer · CAO Iridium Satellite LLC | 卖出（S） | 3,790 | US$31.00 | US$117,490.00 | 47,764 | SEC |
| 2026-04-02 2026-04-03 | AAPL Apple Inc. | O'BRIEN DEIRDRE Officer · Senior Vice President | 卖出（S） | 9,664 | US$255.82 | US$247.22万 | 136,810 | SEC |
| 2026-04-02 2026-04-03 | AAPL Apple Inc. | O'BRIEN DEIRDRE Officer · Senior Vice President | 卖出（S） | 20,338 | US$255.12 | US$518.86万 | 146,474 | SEC |
| 2026-04-01 2026-04-01 | SRE SEMPRA | BIRD JUSTIN CHRISTOPHER Officer · Executive Vice President | 卖出（S） | 1,128 | US$96.69 | US$109,066.32 | 21,631.51 | SEC |
| 2026-02-12 2026-05-11 | FITB FIFTH THIRD BANCORP | Feiger Mitchell Stuart Director | 卖出（S） | 49,175 | US$54.68 | US$268.89万 | 81,752.38 | SEC |
| 2026-02-12 2026-05-11 | FITB FIFTH THIRD BANCORP | Feiger Mitchell Stuart Director | 卖出（S） | 32,769 | US$54.68 | US$179.18万 | 85,615 | SEC |
| 2026-02-12 2026-05-11 | FITB FIFTH THIRD BANCORP | Feiger Mitchell Stuart Director | 卖出（S） | 101 | US$54.68 | US$5,522.68 | 85,514 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| BIRD | 55,470.5302 | 1,814 | 103,134.0764 | 53.78% | B, Q, N |
| IRDM | 226,336.6361 | 0 | 458,078.9779 | 49.41% | B, Q, N |
| IRD | 209,499.0715 | 0 | 430,546.2744 | 48.66% | B, Q, N |